Aligos Therapeutics Inc —— 资产负债表 (NASDAQ:ALGS)

Financials

总资产 265.3 M235.37 M146.69 M151.53 M70.09 M88.53 M 负债总额 45.26 M50.64 M42.79 M59.45 M99.07 M34.99 M 权益总额 220.04 M184.73 M103.9 M92.08 M-28.97 M53.55 M 负债及股东权益总额 265.3 M235.37 M146.69 M151.53 M70.09 M88.53 M 总债务 —————— 净债务 ——————

新闻

H.C. Wainwright维持Aligos Therapeutics股票买入评级，看好pevifoscorvir研发进展

Aligos Therapeutics stock maintains Buy rating at H.C. Wainwright on pevifoscorvir progress

Aligos Therapeutics股价因乙肝二期研究进展而上涨

Aligos Therapeutics stock rises on Phase 2 HBV study progress

Aligos公布乙肝药物二期研究进展

Aligos reports progress on Phase 2 hepatitis B drug study

Aligos Therapeutics任命James Hassard为首席商务官

Aligos therapeutics appoints James Hassard as chief commercial officer

UBS以肝脏疾病管线为由给Aligos Therapeutics股票首次评级为"买入"

Aligos Therapeutics stock initiated with Buy rating at UBS on liver disease pipeline

Aligos报告THR-β激动剂协同减重效果

Aligos reports synergistic weight loss effect with THR-β agonist